Pharmacological Study of Cefoxitin as an Alternative Antibiotic Therapy to Carbapenems in Treatment of Urinary Tract Infections Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli

Cefoxitin could be an alternative to carbapenems in extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) infections. However, pharmacological and clinical data regarding cefoxitin are limited. Using a recent pharmacological model and the MICs of ESBL-EC collected from pyelonephritis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Guet-Revillet, H., Emirian, A., Groh, M., Nebbad-Lechani, B., Weiss, E., Join-Lambert, O., Bille, E., Jullien, V., Zahar, J. R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4135984/
https://ncbi.nlm.nih.gov/pubmed/24777104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02509-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados